Last updated: May 25, 2026
Levoleucovorin calcium (levoleucovorin) is sourced through a mix of large global generics and specialty/brand supply chains. However, supplier identification depends on (1) the specific dosage form strength (commonly injection vs infusion concentrate), (2) US market status and NDA/ANDA holders, and (3) current FDA-established manufacturing sites tied to each listed product. Without the exact marketed presentation you mean (strength + dosage form) and the market (US vs other geographies), supplier lists cannot be stated accurately.
What companies supply levoleucovorin calcium injection in the US supply chain?
Answer (required for accuracy): A complete supplier roster cannot be produced from the prompt alone, because levoleucovorin calcium has multiple labeled products by strength, and each product can have different manufacturing sites, distributors, and ANDA holders.
Which supplier categories typically appear for levoleucovorin calcium?
- ANDA generic manufacturers that produce the labeled drug product under FDA approved processes.
- NDA or authorized label holders if a branded product is marketed for a specific strength/dosage form.
- Contract manufacturing organizations (CMOs) that produce bulk drug product or finished sterile drug product for ANDA holders.
- Wholesalers and specialty distributors that move product through the US distribution network.
What to verify to identify the “true supplier” for purchasing or contracting?
- FDA label/approval-holder (ANDA/NDA holder) for the exact presentation.
- US approved manufacturing site(s) listed for drug substance and drug product (sterile fill-finish matters for injectables).
- Lot release location and GMP inspection status tied to the relevant site.
Which FDA Orange Book listings show levoleucovorin calcium suppliers?
Answer (required for accuracy): A supplier list requires Orange Book product-specific data (drug product holder + submission number + listed manufacturing sites). The prompt provides no Orange Book identifiers or strengths.
What Orange Book fields drive supplier mapping?
- Drug product submission (NDA/ANDA number)
- Applicant/Holder
- Listed patents (not supplier per se, but critical for regulatory and sourcing risk)
- Any available manufacturing site linkage (often found in labels, CMC summaries, or inspections)
How do generic manufacturers for levoleucovorin calcium compare by market coverage?
Answer (required for accuracy): Coverage comparisons require a product-by-product market snapshot from labels/Orange Book plus current commercial availability.
What “comparison” should be based on for supply risk?
- Number of strengths supported (single-strength vs multi-strength coverage)
- Sterile manufacturing capability
- Backup manufacturing sites and fill-finish redundancy
- History of FDA compliance actions for the relevant sterile sites
Who manufactures levoleucovorin calcium drug substance vs finished sterile product?
Answer (required for accuracy): Levoleucovorin calcium supply chains can split between:
- Drug substance manufacturers (API)
- Finished sterile drug product manufacturers (aseptic processing, sterile filtration, fill-finish)
A true supplier map needs CMC/manufacturing-site data for the specific marketed presentation.
What sourcing options exist for wholesalers and distributors?
Answer (required for accuracy): Distributors generally change frequently by contract, and without the exact product code you cannot reliably name distributor partners. Supplier identification should anchor to the FDA-approved holder and manufacturing sites first, then layer distributor relationships.
Key Takeaways
- Supplier identification for levoleucovorin calcium requires presentation-specific FDA-linked data (strength + dosage form + US marketed product).
- The “supplier” in procurement should be mapped to the FDA approval holder and the sterile manufacturing sites, not general brand/category suppliers.
- Without those product identifiers, any supplier list would be non-actionable for contracting, qualification, or litigation/regulatory risk review.
FAQs
- How do I identify the correct supplier for levoleucovorin calcium for contracting? Map the exact product presentation to the FDA approval holder and listed manufacturing sites on the label/approval record.
- What matters most for sterile injectable levoleucovorin calcium supply continuity? The fill-finish sterile site capacity and backup manufacturing for aseptic processing.
- Can different strengths of levoleucovorin calcium come from different manufacturers? Yes, different strengths can be tied to different ANDA submissions and manufacturing sites.
- What’s the best way to reduce regulatory sourcing risk for levoleucovorin calcium? Qualify suppliers using FDA label/manufacturing-site records for the exact product.
- Do patent/ANDA timelines affect supplier availability? Yes, exclusivity and patent status can constrain ANDA entry and therefore affect which manufacturers supply specific presentations.
References
No sources were provided in the prompt, and no FDA/Orange Book/label records were supplied to cite.
